Abstract
“Our findings suggest that the FDA’s deliberative procedures may more adequately capture stakeholder testimony were it to incorporate a pre-hearing event wherein all parties agree to definitions for key points.”
- Journal
- Present Tense: A Journal of Rhetoric in Society
- Published
- 2012-10-16
- CompPile
- Search in CompPile ↗
- Open Access
- OA PDF Gold
- Topics
- Export
- BibTeX RIS
Citation Context
Citation data not yet available for this article.
Citation data is not available for Present Tense: A Journal of Rhetoric in Society. This journal's publisher does not deposit reference lists with CrossRef.
Related Articles
-
Res Rhetorica Apr 2026Arkadiusz Sokolnicki
-
Poroi Feb 2026Using Stasis Theory as a Heuristic for Examining Epistemological Dilemmas in a Post-Truth Landscape ↗Bruce Bowles
-
Res Rhetorica Jan 2026Agnieszka Budzyńska-Daca
-
Rhetorica Jan 2026The Daimonion of Isocrates: Anti-Socratic Polemics and the Power of Politikoi Logoi in the Philippos ↗Tobias Hirsch
-
Philosophy & Rhetoric Oct 2025The Intellectual and Cultural Origins of Chaïm Perelman and Lucie Olbrechts-Tyteca’s New Rhetoric Project: Commentaries on and Translations of Seven Foundational Articles, 1933–1958 ↗Christopher W. Tindale